CTIS2023-503710-69-00进行中(未招募)1 期
Effect of antifungals on the intestinal microbiome – a randomized, controlled, proof-of-concept trial
Amsterdam UMC0 个研究点目标入组 50 人开始时间: 2023年4月11日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64(—)
- 性别
- Male
入选标准
- •Male, 18-35 years of age at the time of signing the informed consent, Healthy, as determined by a responsible physician, based on a medical evaluation including medical history and physical examination. A subject with a clinical abnormality may be included if the investigator agrees that the finding is unlikely to introduce additional risk factors and will not interfere with the study procedures, Capable of giving written informed consent and able to comply with the requirements and restrictions listed in the informed consent form, Normal defecation pattern (defined as =3x/ day and =3x/week)
排除标准
- •Subject has had a major illness in the past 3 months or any significant chronic medical illness that the investigator would deem unfavourable for enrolment, The subject has received an investigational product within three months of day 0 of the current study, Use of prescription or non-prescription drugs and herbal and dietary supplements within 3 months unless in the opinion of the investigator the medication will not interfere with the study procedures or compromise subject safety, Subject has difficulty in donating blood or accessibility of a vein in left or right arm, Subject has donated more than 500 mL of blood in last 3 months, Any other issue that, in the opinion of the investigator, could be harmful to the subject or compromise interpretation of the data, Subject has a past or current gastrointestinal disease which may influence the gut microbiota, including inflammatory bowel disease and medication-treated irritable bowel syndrome, Subject with any history of immunodeficiency, Subject with a history of any type of malignancy, Drinking more than an average of 3 units of alcohol per day, Known allergy to antifungals (any kind), Recent (< 3 months) use of antibiotics (any kind, except for dermal antibiotics), Recent (< 3 months) use of antifungals (any kind, except for dermal antifungals), Planned prolonged (> 4 weeks) travel to tropical countries during the study period
研究者
相似试验
已完成
不适用
Impact of intestinal microbiome on infections, course and outcome of haematological-oncological patients treated with chemotherapygut microbiomeC92.0Acute myeloblastic leukaemia [AML]DRKS00011674niversitätsklinikum Magdeburg12
已完成
不适用
The effect of modulating gut microflora on clinical outcome in elective surgical patients.SepsisISRCTN15806146Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)80
进行中(未招募)
1 期
Impact on the intestinal flora during antibiotic treatmentImpact on the intestinal microbiota during antibiotic treatmentEUCTR2016-003704-31-SEppsala University120
Unknown
不适用
Study of interactions between intestinal microflora, intestinal macrofauna and antibiotic use in adults living in Lambaréné, GaboDigestive SystemGut Flora and faunaPACTR201707002361207Centre de Recherches Médicales de Lambaréné (CERMEL), Albert Schweitzer Hospital Lambaréné, Gabon40
暂停
不适用
Influence of the intestinal microbiome on the risk of spontaneous bacterial peritonitis in patients with decompensated liver cirrhosisK65K74.6Other and unspecified cirrhosis of liverPeritonitisDRKS00026834Klinik und Poliklinik für Innere Medizin II Klinikum rechts der Isar der TU München120
